$22.68
5.17% today
Nasdaq, May 15, 05:48 pm CET
ISIN
US80810D1037
Symbol
SDGR

Schrodinger Inc Stock price

$23.92
-2.62 9.87% 1M
+3.55 17.43% 6M
+4.63 24.00% YTD
+0.67 2.88% 1Y
+0.08 0.34% 3Y
-30.08 55.70% 5Y
-4.72 16.48% 10Y
Nasdaq, Closing price Wed, May 14 2025
+0.16 0.67%
ISIN
US80810D1037
Symbol
SDGR

Key metrics

Market capitalization $1.76b
Enterprise Value $1.36b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 61.34
EV/Sales (TTM) EV/Sales 5.90
P/S ratio (TTM) P/S ratio 7.62
P/B ratio (TTM) P/B ratio 4.70
Revenue growth (TTM) Revenue growth 22.29%
Revenue (TTM) Revenue $230.49m
EBIT (operating result TTM) EBIT $-192.75m
Free Cash Flow (TTM) Free Cash Flow $22.16m
Cash position $512.06m
EPS (TTM) EPS $-2.64
P/E forward negative
P/S forward 6.92
EV/Sales forward 5.36
Short interest 24.78%
Show more

Is Schrodinger Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Schrodinger Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Schrodinger Inc forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Schrodinger Inc forecast:

Buy
88%
Hold
13%

Financial data from Schrodinger Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
230 230
22% 22%
100%
- Direct Costs 88 88
17% 17%
38%
143 143
26% 26%
62%
- Selling and Administrative Expenses 133 133
2% 2%
58%
- Research and Development Expense 196 196
2% 2%
85%
-187 -187
11% 11%
-81%
- Depreciation and Amortization 6.18 6.18
18% 18%
3%
EBIT (Operating Income) EBIT -193 -193
10% 10%
-84%
Net Profit -192 -192
34% 34%
-83%

In millions USD.

Don't miss a Thing! We will send you all news about Schrodinger Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Schrodinger Inc Stock News

Neutral
Business Wire
one day ago
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association Annual Congress, taking place June 12 - 15, 2025, in Milan, Italy. Additional data from this trial will be presented at the International Conference on Malignant Lymphoma, taking...
Neutral
Seeking Alpha
8 days ago
Schrödinger, Inc. (NASDAQ:SDGR ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Affairs Ramy Farid - President & Chief Executive Officer Geoff Porges - Chief Financial Officer Karen Akinsanya - President, R&D & Therapeutics Conference Call Participants Michael Yee - Jefferies Brendan Smith - TD Co...
Neutral
Business Wire
8 days ago
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. today announced financial results for the quarter ended March 31, 2025.
More Schrodinger Inc News

Company Profile

Schrödinger, Inc. provides computational platform to accelerate drug discovery and materials design for biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. The company operates through two segments, Software and Drug Discovery. It segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment develops a pipeline of preclinical and clinical drug discovery programs through its computational platform in collaboration with pharmaceutical companies. Schrödinger, Inc. has strategic collaborations with Twist Bioscience Corporation; and Thermo Fisher Scientific to extend the use of cryo-EM in connection with in silico compound screening to accelerate drug discovery. The company was founded in 1990 and is based in New York.

Head office United States
CEO Ramy Farid
Employees 891
Founded 1990
Website www.schrodinger.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today